Trials / Completed
CompletedNCT00185120
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
A Study on the Efficacy and Safety of Olmesartan Medoxomil and Its Combination With Hydrochlorothiazide Compared With an ACE Inhibitor and Its Combination With a Calcium Channel Blocker in Patients With Stage 2 Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 152 (planned)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of 2 different combinations of high blood pressure medications to treat hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | |
| DRUG | Hydroclorothiazide | |
| DRUG | Benazepril | |
| DRUG | Amlodipine |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2005-09-16
- Last updated
- 2012-01-18
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00185120. Inclusion in this directory is not an endorsement.